|Kits components||1 test + 1 desiccant/ Foil pouch, 20 foil pouches + 1 buffer+1 insert /box.
1 test + 1 desiccant/ Foil pouch, 40 foil pouches + 2 buffer+1 insert /box.
|Technology||Detect 2019-nCoV IgM and IgG antibodies by immuno-capture method.|
|Major Component||1. Mouse anti human IgM&anti human IgG on M and G Line
2. Goat anti-mouse IgG antibody on C Line
3. nCoV recombinant antigens concentration conjugated to Gold Nanoparticles
|Compatible Sample Types||Human serum/plasma/venous whole blood specimen|
|Sample Pad||Glass fiber||Sensitivity||87.3% (95% CI: 80.40% to 92.0%)|
|Wicking Pad||Wood pulp paper||Specificity||100% (95% CI: 94.20% to 100%)|
|Plastic Board (base of the test)||PVC||Storage||Store at 4℃~ 30℃ (39.2℉~ 86℉)|
|Foil Pouch||PET12/AL7/CPP50||No Cross Reactivity||No Cross-reactivity with Influenza A, B, Adenovirus, and many other diseases|
|Pack||40 tests/box, 20 boxes (260*130*65mm)/carton, 12.5 kg (0.06m3)/carton (550*385*295mm)|
As the first batch of test boxes approved by NMPA, our test kit is also certified by CE, U.S. FDA, and other credible authorities, which enable you to import and sell under regional market standards.
Many provincial hospitals and China CDC used our test kit and gave highly appreciate. You got our commitment to the performance of our kit.
Innovita’s test kit is intended for the qualitative detection of IgM and IgG antibodies against COVID-19, compliant with in vitro diagnostic use standards.
The kit is for the auxiliary diagnosis, detecting recent cases and previous cases of COVID-19. The confirmation or exclusion of infection should be combined with the patient’s clinical manifestations and other laboratory tests.
The test kit contains IgM and IgG combined detection. This 15-minute test kit from Innovita returns immediate results, which is ideal for POTC (Point-of-care Testing).
It will help speed up the process of COVID-19 testing, allowing institutions to screen more patients and prevent any further spread of the virus.
We conducted clinical research with 5 institutions, collecting 447 cases. Innovita’s test kit comes with a sensitivity of 87.3% and specificity of 100%.
During the asymptomatic phase, we may get a false negative result. So the test results of our kit are for clinical reference only. Diagnosis and treatment should combine with further tests.
Our test kit is convenient for professionals to use because the test results can be spotted with the naked eye. For example, one purple band appearing at the control line (C) means a negative sample and two purple bands (T and C) mean a positive case.
Equipment-free design and accurate results are potentially useful for areas with limited
We built up full quality control and risk control processes to ensure that you can get stable and reliable test kits. Some of the tests we conducted are as follow:
• Sensitivity Test
• Specificity Test
• Hook Effect Test
• Specimen Stability Test
Contact us for more test reports.
Leading Manufacturer in the Biological Technology Industry
Established in 2006 in Beijing, Innovita Biological Technology Co., Ltd. is a Chinese high-tech enterprise specialized in R&D, manufacturing, and marketing Fertility, Infectious Diseases, Sexually Transmitted Diseases, TORCH, Respiratory Diseases, Hepatitis, Drug Abuse, Tumor Marker, Gastrointestinal Diseases and Cardiac marker tests. In 2011 Innovita extended a new plant with 250 acres (160,000 square meters) in Tangshan. We can reach an output of 20 million tests each year.
We attach great importance to independent research and development and advanced scientific management. Our laboratory is equipped with international advanced instruments and equipment. More than 40% of researchers have a master’s degree in our independent R&D team.
Innovita fights for the health of people all over the world. We have offered a wide range of test products and services for our clients at home and abroad. We are always ready to add ammunition to people around the world who fight against COVID-19.
Recently, the medical treatment team of the Central Guidance Group received a donation of 50,000 pcs of 2019-nCoV Ab Tests from your company and have distributed them to designated hospitals that specially receive patients with COVID-19 for antibody diagnosis (for details, see the attached table). It effectively helped clinical diagnosis and improved the efficiency of medical treatment, and has played an active role in fighting the COVID-19 epidemic.
INNOVITA is a leading manufacturer of diagnostic solutions for respiratory pathogens diagnosis, specialized in colloidal gold, real-time PCR, chemiluminescence, ELISA and biochips. We strive for a more efficient healthcare system to enhance the health and well-being of people all over the world.Contact Supplier NOW
China Encourages Medical Supply Exports and Enhances Quality SupervisionApr 07, 2020
The Ultimate Guide to Importing Masks From ChinaApr 07, 2020